Business Wire

NY-AQARA

Share
Aqara Launches AI-Enabled Camera Hub G3

Aqara, a leading provider of smart home products, announced today the launch of its next-gen flagship home security camera, the Camera Hub G3. The new camera is a 2K, pan-and-tilt camera with the local facial and gesture recognition features, and it integrates a built-in Zigbee 3.0 hub, allowing the device to connect up to 128 Aqara accessories*. It is now available on the Aqara Amazon brand stores in the US , Canada and France , and is also expected to be sold by authorized Aqara retailers in North America, Europe and Asia in the following weeks**.

Thanks to a powerful NPU-equipped processor, the Aqara Camera Hub G3 supports facial recognition and gesture recognition features, both of which can be used to trigger home automations. Users can configure to receive push notifications when their young kids arrive home or when a stranger is detected (i.e. a familiar face was not detected), or to stop video recording when the face of a family member or a preset hand gesture is recognized. The AI-enabled features will make homes safer, and make people’s lives even easier as users can now trigger home automation with certain hand gestures or simply a recognized face.

The G3 camera hub also supports automatic cruising, face tracking as well as pet tracking, all enabled by the 110° wide-angle lens and the pan-and-tilt motor which provides up to 340° rotation angle. The pan-and-tilt motor can be controlled manually, by the preset cruising path, or via home automations (for example, to turn to the front door when Door & Window Sensor is triggered). Combined with the high-resolution 2304×1296 pixel sensor and the infrared night vision enabled by the 940 nm LEDs, which are invisible at night, the G3 protects homes in 360-degree with no blind spot, day and night.

Compared to the previous G2H Camera Hub, the new G3 provides other advanced features including:

  • Wider compatibility with third-party platforms : as a camera it supports not only HomeKit Secure Video*** but also streaming to Amazon Alexa and Google Assistant smart displays, while as a hub it allows connected child devices to support a wide range of third-party ecosystems and voice assistants, such as HomeKit, Alexa, Google Home, IFTTT, and more;
  • Local infrared control : the built-in IR controller allows the G3 to automate the infrared-compatible devices, and the IR automation is local which means it remains functioning without the Internet connection;
  • Dual-band Wi-Fi support : both 2.4GHz and 5GHz Wi-Fi networks are supported;
  • Privacy protection : it is equipped with a privacy shutter that physically covers the camera lens, and the shutter can be activated manually and automatically;
  • Type-C port with video out : it uses the modern and universal connector that supports low-latency, high-definition video output via UVC protocol.

To celebrate the launch, Aqara is now offering limited-time discounts for the new Camera Hub G3 on its Amazon brand stores. North American customers will enjoy a 20% discount at check with the promo code USG3PRGE in the US and Canada , and the code will be valid through Nov 24, 2021. Aqara also offers French customers a 20€ OFF discount at its Amazon.fr store , with the promo code CAMERAG3FR, and the offering will expire on Nov 25, 2021.

For more details of the G3 camera hub, please visit our website .

* To connect up to 128 devices, Zigbee routers/repeaters such as Smart Wall Switch (With Neutral) and Smart Plug are required.

** Product availability may vary among different retail channels, and could be updated all the time. It’s recommended to check with the regional retailer(s) for real time availability.

*** In HomeKit Secure Video mode, the camera records in Full HD 1080p and Pan/Tilt controls are not available due to the current limitations of HomeKit technology.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release

Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release

SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f

Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 02:15:00 CET | Press release

Through the Extreme Exchange (IX) acquisition, Megaport gains seven Internet Exchanges and access to 40+ data centres across India’s fastest-growing digital hubs. Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly thr

IonQ and QuantumBasel Expand Long-Term Partnership in Next-Generation Quantum Systems17.12.2025 22:10:00 CET | Press release

Extension solidifies QuantumBasel as IonQ’s Innovation Center in Europe; adds IonQ Tempo and next-generation system to advance quantum commercialization IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an expanded agreement with QuantumBasel, the quantum initiative of uptownBasel, Switzerland’s innovation campus. The extended contract grants QuantumBasel ownership of its existing IonQ Forte Enterprise system and secures ownership of a next-generation Tempo system. This new agreement brings the total deal value of the QuantumBasel and IonQ partnership to over $60 million and extends IonQ’s on-site presence in Switzerland four more years, continuing through 2029. QuantumBasel is IonQ’s official Innovation Center in Europe, serving as a hub for European industry, academia, and research institutions to explore practical quantum computing applications and access IonQ’s latest enterprise-grade systems. “Our extended partnership with QuantumBasel represents a cornerston

Suzano Starts Up New Production Line, Boosting Its Fluff Pulp Capacity by 400%17.12.2025 21:50:00 CET | Press release

A R$490 million investment expands the supply of raw material used in the production of absorbent items Suzano, the world’s largest pulp producer, has commenced operations this week at its new fluff pulp production line located in its Limeira unit in Brazil’s São Paulo state. This R$490 million investment increases Suzano’s total fluff pulp production capacity by more than 400%, from 100,000 to 440,000 tonnes per year. The project involved converting the existing pulp line at the Limeira unit into a flexible machine, capable of producing both Eucafluff® and market pulp. Eucafluff® is used in the production of absorbent and personal hygiene products, such as baby and adult diapers, sanitary pads and pet pads. Then market pulp is supplied for making products including toilet paper, printing and writing papers, and paper packaging. Launched in 2015, Eucafluff® is the world’s first fluff pulp made from eucalyptus, delivering unique advantages like enhanced softness and flexibility, which t

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye